Literature DB >> 22298977

Hepatitis C virus treatment complicated by rheumatoid arthritis.

Meredith Borman1, Mark G Swain.   

Abstract

Entities:  

Year:  2011        PMID： 22298977      PMCID： PMC3264934     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  23 in total

1.  Diagnosis, management, and treatment of hepatitis C.

Authors:  Doris B Strader; Teresa Wright; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

2.  Etanercept treatment to enable successful hepatitis C virus clearance in a patient with rheumatoid arthritis.

Authors:  Alison B Jazwinski; Janet Jezsik; Stacy P Ardoin; Rex M McCallum; Hans L Tillmann
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-11

3.  Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection.

Authors:  B Kallinowski; K Haseroth; G Marinos; C Hanck; W Stremmel; L Theilmann; M V Singer; S Rossol
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

4.  Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study.

Authors:  Nizar N Zein
Journal:  J Hepatol       Date:  2005-03       Impact factor: 25.083

5.  Safety of disease modifying anti-rheumatic agents in rheumatoid arthritis patients with chronic viral hepatitis.

Authors:  M Y Mok; W L Ng; M F Yuen; R W Wong; C S Lau
Journal:  Clin Exp Rheumatol       Date:  2000 May-Jun       Impact factor: 4.473

6.  Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium.

Authors: 
Journal:  J Viral Hepat       Date:  1999-01       Impact factor: 3.728

Review 7.  Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review.

Authors:  Alexandra M G Brunasso; Matteo Puntoni; Andrea Gulia; Cesare Massone
Journal:  Rheumatology (Oxford)       Date:  2011-06-20       Impact factor: 7.580

8.  Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity.

Authors:  H Zylberberg; A C Rimaniol; S Pol; A Masson; D De Groote; P Berthelot; J F Bach; C Bréchot; F Zavala
Journal:  J Hepatol       Date:  1999-02       Impact factor: 25.083

Review 9.  The case for hepatitis C arthritis.

Authors:  Itzhak Rosner; Michael Rozenbaum; Elias Toubi; Aharon Kessel; Jochanan E Naschitz; Eli Zuckerman
Journal:  Semin Arthritis Rheum       Date:  2004-06       Impact factor: 5.532

Review 10.  Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection.

Authors:  L H Calabrese; N Zein; D Vassilopoulos
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.